# EDGAR Filing Document

**Accession Number:** 0001011060
**File Stem:** 0001493152-25-016129
**Filing Date:** 2025-9
**Character Count:** 9900
**Document Hash:** 255b718aa7345af3ef3af66096d03452
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-016129.hdr.sgml**: 20250929

**ACCESSION NUMBER**: 0001493152-25-016129

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250929

**DATE AS OF CHANGE**: 20250929

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Nordicus Partners Corp
- **CENTRAL INDEX KEY:** 0001011060
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 043186647
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-48655
- **FILM NUMBER:** 251357975

**BUSINESS ADDRESS:**
- **STREET 1:** 280 SOUTH BEVERLY DR.
- **STREET 2:** SUITE 505
- **CITY:** BEVERLY HILLS
- **STATE:** CA
- **ZIP:** 90212
- **BUSINESS PHONE:** 508-523-3141

**MAIL ADDRESS:**
- **STREET 1:** 280 SOUTH BEVERLY DR.
- **STREET 2:** SUITE 505
- **CITY:** BEVERLY HILLS
- **STATE:** CA
- **ZIP:** 90212

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** EKIMAS Corp
- **DATE OF NAME CHANGE:** 20200406

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AdvanSource Biomaterials Corp
- **DATE OF NAME CHANGE:** 20081021

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CARDIOTECH INTERNATIONAL INC
- **DATE OF NAME CHANGE:** 19960321
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AC Nordic ApS
- **CENTRAL INDEX KEY:** 0002046935

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** G7
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** DYREHAVEVEJ 3B
- **CITY:** KLAMPENBORG
- **STATE:** G7
- **ZIP:** DK-2930
- **BUSINESS PHONE:** 4531380834

**MAIL ADDRESS:**
- **STREET 1:** DYREHAVEVEJ 3B
- **CITY:** KLAMPENBORG
- **STATE:** G7
- **ZIP:** DK-2930

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 1)**

**Nordicus Partners Corp**

*(Name of Issuer)*

**Common Stock**

*(Title of Class of Securities)*

**28265K205**

*(CUSIP Number)*

**AC Nordic ApS**<br>Strandvejen 60, 5.<br>Hellerup G7 DK-2900<br>(45) 31 38 08 34

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**07/30/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **28265K205** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**AC Nordic ApS** | Name of reporting person<br>**AC Nordic ApS** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**G7** | Citizenship or place of organization<br>**G7** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**3119335.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**3119335.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**3119335.00** | Aggregate amount beneficially owned by each reporting person<br>**3119335.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**17.42%** | Percent of class represented by amount in Row (11)<br>**17.42%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock

**(b) Name of Issuer:**
Nordicus Partners Corp

**(c) Address of Issuer's Principal Executive Offices:**
280 SOUTH BEVERLY DR., SUITE 505, BEVERLY HILLS, CA, 90212

The issuer is Nordicus Partners Corporation, a Delaware corporation (the "Company"). The title of the class of equity securities to which this Statement relates is common stock, par value $0.001 per share ("Shares"). The Company's principal executive office is: 280 South Beverly Dr., Suite 505, Beverly Hills, CA 90212.

All share and per-share amounts in this Schedule reflect a 1-for-10 reverse stock split effective November 8, 2024.

**Item 4. Purpose of Transaction**

On February 18, 2025, the Reporting Person acquired 2,000 Shares in a private transaction from a third party that is not an affiliate of the Company on a cost basis of $5.00 per Share, and sold an aggregate number of 7,500 Shares on a cost basis of $1.90 per Share in private transactions. On May 28, 2025, the Reporting Person gifted 109,750 Shares to another shareholder who is not an affiliate of the Company. On May 28, 2025, the Reporting Person gifted 113,095 Shares to GK Partners ApS. On June 2, 2025, the Reporting Person acquired 1,982 Shares in a private transaction a third party that is not an affiliate of the Company on a cost basis of $8.85 per Share. On June 16, 2025, the Reporting Person acquired 35,000 Shares from the Company on a cost basis of $4.00 per Share. On July 2, 3 and 30, 2025, the Reporting Person respectively acquired 25,000, 42,500 and 100,000 Shares from the Company, each on a cost basis of $1.90 per Share.

The purpose of all of these transactions - both the acquisition and dispositions - was a part of the Reporting Person's long-term strategy for asset diversification and liquidity.

The foregoing transactions were exempt under the Securities Act of 1933, as amended (the "Securities Act"). None of such shares was or will be registered under the Securities Act or any state securities laws, and unless so registered, may not be reoffered or resold in the United States absent such registration or an applicable exemption therefrom, or in a transaction not subject to the registration requirements of the Securities Act of 1933 and other applicable securities laws.

Except as stated above, there are no plans or proposals which the Reporting Persons or Mr. Jensen have which relate to or would result in: (a) The acquisition by any person of additional securities of the issuer, or the disposition of securities of the issuer; (b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the issuer or any of its subsidiaries; (c) A sale or transfer of a material amount of assets of the issuer or any of its subsidiaries; (d) Any change in the present board of directors or management of the issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) Any material change in the present capitalization or dividend policy of the issuer; (f) Any other material change in the issuer's business or corporate structure, including but not limited to, if the issuer is a registered closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by section 13 of the Investment Company Act of 1940; (g) Changes in the issuer's charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the issuer by any person; (h) Causing a class of securities of the issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) A class of equity securities of the issuer becoming eligible for termination of registration pursuant to section 12(g)(4) of the Act; or (j) Any action similar to any of those enumerated above.

**Item 5. Interest in Securities of the Issuer**

**(a)**
As of the date of this Schedule, the Reporting Person beneficially owned 3,119,335 Shares, constituting 17.42% of the outstanding Shares. The percentage of Shares owned is based upon 17,901,551 Shares outstanding as of August 26, 2025, based on inquiry of the Company's transfer agent.

**(b)**
The Reporting Person has the sole power to vote, direct the vote, dispose and direct the disposition of 3,119,335 Shares.

**(c)**
The Shares were acquired on the dates set forth above in Item 4.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Except as described in Items 3 and 4, there are no contracts, arrangements, understandings or relationships (legal or otherwise) between the Reporting Person and any other person with respect to any securities of the Company, including but not limited to transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** AC Nordic ApS

**Signature:** /s/ Torben Steen Jensen

**Name/Title:** Torben Steen Jensen

**Date:** 09/29/2025